{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T04:43:12Z","timestamp":1767933792032,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T00:00:00Z","timestamp":1613433600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T00:00:00Z","timestamp":1613433600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Acute post-cataract endophthalmitis (APE) is a rare complication potentially causing irreversible visual loss. A 10-year study of APE was conducted to determine its incidence, microbiological spectra and antibiotic resistance profile of APE-related pathogens at a major tertiary referral center in Brazil.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>APE cases reported between January 2010 and December 2019 were included. Phacoemulsification and extracapsular cataract techniques were eligible; combined procedures, traumatic and congenital cataract were excluded. Vitreous samples were cultured and antimicrobial resistance was compared for the periods of 2010\u20132014 and 2015\u20132019. The results were analyzed with Fisher\u2019s exact test.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Our sample consisted of 40,491 cataract surgeries and 51 (0.126%) APE cases. Culture was positive in 35 cases (71.4%), of which 31 (88.6%) Gram-positive, 3 (8.6%) Gram-negative, and 1 (2.9%) fungal. The most frequently isolated organism was <jats:italic>Staphylococcus epidermidis<\/jats:italic> (n\u2009=\u200917\/35, 48.6%), followed by <jats:italic>Staphylococcus aureus<\/jats:italic> (n\u2009=\u20094\/35, 11.4%). From 2010\u20132014 to 2015\u20132019, antimicrobial resistance increased against moxifloxacin (11.1\u201354.5%, <jats:italic>p<\/jats:italic>\u2009=\u20090.07), ciprofloxacin (54.5\u201372.7%, <jats:italic>p<\/jats:italic>\u2009=\u20090.659) and oxacillin (66.7\u201393.3%, <jats:italic>p<\/jats:italic>\u2009=\u20090.13).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The observed incidence and microbial spectra were compatible with previous studies. A trend towards growing moxifloxacin and ciprofloxacin resistance was observed. Surveillance remains crucial to prevent treatment failure from antimicrobial resistance.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40942-021-00280-1","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T17:20:26Z","timestamp":1613582426000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Surveillance of post-cataract endophthalmitis at a tertiary referral center: a 10-year critical evaluation"],"prefix":"10.1186","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1815-4644","authenticated-orcid":false,"given":"Juliana Mika","family":"Kato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiza Manhezi Shin","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maura Salaroli","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavia","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Goldbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio Luis Gianotti","family":"Pimentel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o N\u00f3brega","family":"de Almeida Junior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joyce Hisae","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,16]]},"reference":[{"key":"280_CR1","unstructured":"National Eye Institute. Cataracts Defined-Projections for Cataract (2010-2030-2050). https:\/\/nei.nih.gov\/eyedata\/cataract. Accessed 10 Apr 2020."},{"key":"280_CR2","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1590\/S0004-27492010000600007","volume":"73","author":"GB Melo","year":"2011","unstructured":"Melo GB, Bispo PJM, Regatieri CVS, Yu MCZ, Pignatari ACC, H\u00f6fling-Lima AL. Incidence of endophthalmitis after cataract surgery (2002\u20132008) at a Brazilian university-hospital. Arq Bras Oftalmol. 2011;73:505\u20137.","journal-title":"Arq Bras Oftalmol"},{"key":"280_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jcrs.2012.10.037","volume":"39","author":"E Friling","year":"2013","unstructured":"Friling E, Lundstr\u00f6m M, Stenevi U, Montan P. Six-year incidence of endophthalmitis after cataract surgery: Swedish national study. J Cataract Refract Surg. 2013;39:15\u201321.","journal-title":"J Cataract Refract Surg"},{"key":"280_CR4","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1136\/bjo.2008.147520","volume":"93","author":"ZI Carrim","year":"2009","unstructured":"Carrim ZI, Richardson J, Wykes WN. Incidence and visual outcome of acute endophthalmitis after cataract surgery\u2013the experience of an eye department in Scotland. Br J Ophthalmol. 2009;93:721\u20135.","journal-title":"Br J Ophthalmol"},{"key":"280_CR5","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.jcrs.2007.02.032","volume":"33","author":"Endophthalmitis Study Group, European Society of Cataract & Refractive Surgeons","year":"2007","unstructured":"Endophthalmitis Study Group, European Society of Cataract & Refractive Surgeons. Prophylaxis of postoperative endophthalmitis following cataract surgery: Results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg. 2007;33:978\u201388.","journal-title":"J Cataract Refract Surg"},{"key":"280_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2415-12-2","volume":"12","author":"P Romero-Aroca","year":"2012","unstructured":"Romero-Aroca P, M\u00e9ndez-Marin I, Salvat-Serra M, Fern\u00e1ndez-Ballart J, Almena-Garcia M, Reyes-Torres J. Results at seven years after the use of intracamerular cefazolin as an endophthalmitis prophylaxis in cataract surgery. BMC Ophthalmol. 2012;12:1\u20137.","journal-title":"BMC Ophthalmol"},{"key":"280_CR7","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.ophtha.2006.08.038","volume":"114","author":"M Moshirfar","year":"2007","unstructured":"Moshirfar M, Feiz V, Vitale AT, Wegelin JA, Basavanthappa S, Wolsey DH. Endophthalmitis after uncomplicated cataract surgery with the use of fourth-generation fluoroquinolones: a retrospective observational case series. Ophthalmology. 2007;114:686\u201391.","journal-title":"Ophthalmology"},{"key":"280_CR8","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.ophtha.2011.11.023","volume":"119","author":"L Keay","year":"2012","unstructured":"Keay L, Gower EW, Cassard SD, Tielsch JM, Schein OD. Postcataract surgery endophthalmitis in the United States: Analysis of the complete 2003 to 2004 medicare database of cataract surgeries. Ophthalmology. 2012;119:914\u201322.","journal-title":"Ophthalmology"},{"key":"280_CR9","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1001\/archopht.1995.01100120009001","volume":"113","author":"Endophthalmitis Vitrectomy Study Group","year":"1995","unstructured":"Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study: a randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol. 1995;113:1479\u201396.","journal-title":"Arch Ophthalmol"},{"key":"280_CR10","doi-asserted-by":"publisher","first-page":"165","DOI":"10.5935\/0004-2749.20170040","volume":"80","author":"IV Vieira","year":"2017","unstructured":"Vieira IV, Boianovsky C, Saraiva TJ, de Godoy RB, Lake J. Safety and efficacy of intracameral moxifloxacin injection for prophylaxis of endophthalmitis after phacoemulsification. Arq Bras Oftalmol. 2017;80:165\u20137.","journal-title":"Arq Bras Oftalmol"},{"key":"280_CR11","doi-asserted-by":"publisher","first-page":"e837","DOI":"10.6061\/clinics\/2019\/e837","volume":"74","author":"T Tanaka","year":"2019","unstructured":"Tanaka T, Ferreira BFA, Oliveira LMS, Kato JM, Gioia TSRD, Rossi F, et al. Diagnostic value of pediatric blood culture bottles for acute postoperative endophthalmitis. Clinics. 2019;74:e837.","journal-title":"Clinics"},{"key":"280_CR12","volume-title":"Manual of clinical microbiology","year":"2015","unstructured":"Jorgensen J, Pfaller M, Carooll K, Funke G, Landry M, Rchter S, Warnock D, editors. Manual of clinical microbiology. 11th. ed. Washington, DC: ASM Press; 2015.","edition":"11"},{"key":"280_CR13","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.diagmicrobio.2017.04.008","volume":"88","author":"T Tanaka","year":"2017","unstructured":"Tanaka T, Oliveira LMF, Ferreira BFA, Kato JM, Rossi F, Correa KLG, et al. Bactec\u2122 blood culture bottles allied to MALDI-TOF mass spectrometry: rapid etiologic diagnosis of bacterial endophthalmitis. Diagn Microbiol Infect Dis. 2017;88:222\u20134.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"280_CR14","unstructured":"CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 29th ed. CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2019."},{"key":"280_CR15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S0886-3350(02)01483-9","volume":"29","author":"Y Nagaki","year":"2003","unstructured":"Nagaki Y, Hayasaka S, Kadoi C, Matsumoto M, Yanagisawa S, Watanabe K, et al. Bacterial endophthalmitis after small incision cataract surgery: Effect of incision placement and intraocular lens type. J Cataract Refract Surg. 2003;29:20\u20136.","journal-title":"J Cataract Refract Surg"},{"key":"280_CR16","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1016\/j.ophtha.2014.02.001","volume":"121","author":"RC Gentile","year":"2014","unstructured":"Gentile RC, Shukla S, Shah M, Ritterband DC, Engelbert M, Davis A, Hu DN. Microbiological spectrum and antibiotic sensitivity in endophthalmitis: a 25-year review. Ophthalmology. 2014;121:1634\u201342.","journal-title":"Ophthalmology"},{"key":"280_CR17","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s15010-013-0530-z","volume":"42","author":"HW Kim","year":"2014","unstructured":"Kim HW, Kim SY, Chung IY, Lee JE, Lee JE, Park JM, Park JM, Han YS, Oum BS, Byon IS, Yun IH, Yoon HS, Park D, Jeong WJ, Yu BC, Park I, Bae T, Nam KY, Lee SJ. Emergence of Enterococcus species in the infectious microorganisms cultured from patients with endophthalmitis in South Korea. Infection. 2014;42:113\u20138.","journal-title":"Infection"},{"key":"280_CR18","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s10792-016-0288-2","volume":"37","author":"YT Teng","year":"2017","unstructured":"Teng YT, Teng MC, Kuo HK, Fang PC, Wu PC, Chen CH, Kuo MT, Yang IH, Chen YJ. Isolates and antibiotic susceptibilities of endophthalmitis in postcataract surgery: a 12-year review of culture-proven cases. Int Ophthalmol. 2017;37:513\u20138.","journal-title":"Int Ophthalmol"},{"key":"280_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3109\/09273948.2015.1075559","volume":"25","author":"A Sadaka","year":"2017","unstructured":"Sadaka A, Durand ML, Sisk R, Gilmore MS. Staphylococcus aureus and its bearing on ophthalmic disease. Ocul Immunol Inflamm. 2017;25:111\u201321.","journal-title":"Ocul Immunol Inflamm"},{"key":"280_CR20","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.oret.2017.08.025","volume":"2","author":"NA Yannuzzi","year":"2018","unstructured":"Yannuzzi NA, Patel NA, Relhan N, Tran KD, Si N, Albini TA. Clinical features, antibiotic susceptibilities, and treatment outcomes of endophthalmitis caused by Staphylococcus epidermidis. Ophthalmol Retina. 2018;2:396\u2013400.","journal-title":"Ophthalmol Retina"},{"key":"280_CR21","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1001\/jamaophthalmol.2017.1826","volume":"135","author":"JD Stringham","year":"2017","unstructured":"Stringham JD, Relhan N, Miller D, Flynn HW Jr. Trends in fluoroquinolone nonsusceptibility among coagulase-negative staphylococcus isolates causing endophthalmitis, 1995\u20132016. JAMA Ophthalmol. 2017;135:814\u20135.","journal-title":"JAMA Ophthalmol"},{"key":"280_CR22","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s40123-018-0138-6","volume":"7","author":"NK George","year":"2018","unstructured":"George NK, Stewart MW. The routine use of intracameral antibiotics to prevent endophthalmitis after cataract surgery: how good is the evidence? Ophthalmol Ther. 2018;7:233\u201345.","journal-title":"Ophthalmol Ther"},{"issue":"1","key":"280_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0161-6420(01)00899-5","volume":"109","author":"TA Ciulla","year":"2002","unstructured":"Ciulla TA, Starr MB, Masket S. Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update. Ophthalmology. 2002;109(1):13\u201324.","journal-title":"Ophthalmology"},{"key":"280_CR24","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/S0161-6420(91)32052-9","volume":"98","author":"MG Speaker","year":"1991","unstructured":"Speaker MG, Menikoff JA. Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology. 1991;98:1769\u201375.","journal-title":"Ophthalmology"},{"key":"280_CR25","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jcrs.2014.04.040","volume":"41","author":"MM Nentwich","year":"2015","unstructured":"Nentwich MM, Ta CN, Kreutzer TC, Li B, Schwarzbach F, Yactayo-Miranda YM, et al. Incidence of postoperative endophthalmitis from 1990 to 2009 using povidone-iodine but no intracameral antibiotics at a single academic institution. J Cataract Refract Surg. 2015;41:58\u201366.","journal-title":"J Cataract Refract Surg"},{"key":"280_CR26","doi-asserted-by":"publisher","first-page":"e13108","DOI":"10.5812\/jjm.13108","volume":"7","author":"M Panahibazaz","year":"2014","unstructured":"Panahibazaz M, Moosavian M, Khataminia G, Feghhi M, Yazdi F, Abbasi Montazeri E. Sub-conjunctival injection of antibiotics vs. povidone-iodine drop on bacterial colonies in phacoemulsification cataract surgery. Jundishapur J Microbiol. 2014;7:e13108.","journal-title":"Jundishapur J Microbiol"},{"key":"280_CR27","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1016\/j.ophtha.2016.02.019","volume":"123","author":"C Creuzot-Garcher","year":"2016","unstructured":"Creuzot-Garcher C, Benzenine E, Mariet AS, de Lazzer A, Chiquet C, Bron AM, et al. Incidence of acute postoperative endophthalmitis after cataract surgery a nationwide study in france from 2005 to 2014. Ophthalmology. 2016;123:1414\u201320.","journal-title":"Ophthalmology"},{"key":"280_CR28","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1167\/iovs.03-1000","volume":"45","author":"J Li","year":"2004","unstructured":"Li J, Morlet N, Ng JQ, Semmens JB, Knuiman MW, Team E. Significant nonsurgical risk factors for endophthalmitis after cataract surgery: EPSWA fourth report. Invest Ophthalmol Vis Sci. 2004;45:1321\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"280_CR29","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.ophtha.2006.11.025","volume":"114","author":"M Lundstrom","year":"2007","unstructured":"Lundstrom M, Wejde G, Stenevi U, Thorburn W, Montan P. Endophthalmitis after cataract surgery: a nationwide prospective study evaluating incidence in relation to incision type and location. Ophthalmology. 2007;114:866\u201370.","journal-title":"Ophthalmology"},{"key":"280_CR30","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.ajo.2005.01.025","volume":"139","author":"JJ Miller","year":"2005","unstructured":"Miller JJ, Scott IU, Flynn HW, Smiddy WE, Newton J, Miller D. Acute-onset endophthalmitis after cataract surgery (2000\u20132004): incidence, clinical settings, and visual acuity outcomes after treatment. Am J Ophthalmol. 2005;139:983\u20137.","journal-title":"Am J Ophthalmol"},{"key":"280_CR31","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1136\/bjophthalmol-2017-311051","volume":"102","author":"RC Bowen","year":"2018","unstructured":"Bowen RC, Zhou AX, Bondalapati S, Lawyer TW, Snow KB, Evans PR, et al. Comparative analysis of the safety and efficacy of intracameral cefuroxime, moxifloxacin and vancomycin at the end of cataract surgery: a meta-analysis. Br J Ophthalmol. 2018;102:1268\u201376.","journal-title":"Br J Ophthalmol"},{"key":"280_CR32","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.jcrs.2014.05.038","volume":"41","author":"S Sharma","year":"2015","unstructured":"Sharma S, Sahu SK, Dhillon V, Das S, Rath S. Reevaluating intracameral cefuroxime as a prophylaxis against endophthalmitis after cataract surgery in India. J Cataract Refract Surg. 2015;41:393\u20139.","journal-title":"J Cataract Refract Surg"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-021-00280-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40942-021-00280-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-021-00280-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T17:36:11Z","timestamp":1613583371000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalretinavitreous.biomedcentral.com\/articles\/10.1186\/s40942-021-00280-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,16]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["280"],"URL":"https:\/\/doi.org\/10.1186\/s40942-021-00280-1","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,16]]},"assertion":[{"value":"25 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Institutional Ethics Committee CapPesq 47914315.7.0000.0068.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Consent for publication"}},{"value":"The authors have no competing interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Competing interests"}}],"article-number":"14"}}